eCourse art

eCourse

2020 Section 101 Update and Practical Guidance: Bio/Pharma and Software/Business Methods

Contains material from Dec 2020

2020 Section 101 Update and Practical Guidance: Bio/Pharma and Software/Business Methods
Not yet rated

Technical Questions?
512.475.6700
service@utcle.org



Session 1: Section 101 Update: Alice at Six - Hear an update on this year’s patentable subject matter cases and other developments. What have we learned over the last six years and what can we expect moving forward? Plus, hear some suggested do’s and don’ts for prosecution and litigation.

Session 2: Section 101 in Two Realms: Practical Tips for Addressing Ongoing Challenges in Getting Patents in the Life Sciences and in Software - A year after the newest USPTO guidelines on patent eligibility, our panelists discuss prosecution suggestions in the software/business and the bio/pharma technical areas, in particular, our best pragmatic advice on managing your 101 challenges at USPTO and including a focus on patent applications concerning COVID-19 diagnostic tests, serology tests, vaccines, and therapeutics as examples for the pharma challenges and opportunities we are facing.

Includes: Video Audio Paper Slides

  • Total Credit Hours:
  • 1.50
  • Credit Info
  • TX, CA
  • TX MCLE credit expires: 12/31/2021

Preview mode. You must be signed in and have purchased this eCourse to have full access.
Preview Sessions
Credit

1. Section 101 Update: Alice at Six (Dec 2020)

Steve Borgman, Janice Le Ta, Michael W. Piper, Gina N. Shishima

0.75 0.00 0.00 0.75
Preview Materials

Download session materials for offline use

(mp4)
46 mins
(mp3)
46 mins
(pdf)
128 pgs
Session 1 — 46 mins, credit 0.75
Section 101 Update: Alice at Six (Dec 2020)

Hear an update on this year’s patentable subject matter cases and other developments. What have we learned over the last six years and what can we expect moving forward? Plus, hear some suggested do’s and don’ts for prosecution and litigation.

Originally presented at: Nov 2020 Advanced Patent Law Institute

Steve Borgman, Kilpatrick Townsend & Stockton LLP - Houston, TX
Janice Le Ta, Perkins Coie LLP - Austin, TX
Michael W. Piper, Conley Rose, PC - Plano, TX
Gina N. Shishima, Norton Rose Fulbright - Austin, TX

2. Section 101 in Two Realms: Practical Tips for Addressing Ongoing Challenges in Getting Patents in the Life Sciences and in Software (Dec 2020)

Steve Borgman, Michael W. Piper, Gina N. Shishima

0.75 0.00 0.00 0.75
Preview Materials

Download session materials for offline use

(mp4)
40 mins
(mp3)
40 mins
(pdf)
55 pgs
(pdf)
52 pgs
Session 2 — 40 mins, credit 0.75
Section 101 in Two Realms: Practical Tips for Addressing Ongoing Challenges in Getting Patents in the Life Sciences and in Software (Dec 2020)

A year after the newest USPTO guidelines on patent eligibility, our panelists discuss prosecution suggestions in the software/business and the bio/pharma technical areas, in particular, our best pragmatic advice on managing your 101 challenges at USPTO and including a focus on patent applications concerning COVID-19 diagnostic tests, serology tests, vaccines, and therapeutics as examples for the pharma challenges and opportunities we are facing.

Originally presented at: Nov 2020 Advanced Patent Law Institute

Steve Borgman, Kilpatrick Townsend & Stockton LLP - Houston, TX
Michael W. Piper, Conley Rose, PC - Plano, TX
Gina N. Shishima, Norton Rose Fulbright - Austin, TX

Subscribe to Our Hooked on CLE Monthly Newsletter